期刊论文详细信息
World Journal of Surgical Oncology
Partial nephrectomy using porcine small intestinal submucosa
Andres J Schrader1  Mark Schrader1  Friedemann Zengerling1  Sandra Waalkes2  Florian Jentzmik1  Robert Hefty1  Robert de Petriconi1  Thomas J Schnoeller1 
[1] Department of Urology, Ulm University Medical Center, Prittwitzstrasse 43, D-89075 Ulm, Germany;Department of Urology, Hannover Medical School, Carl-Neuberg-Str. 1, D-30625 Hannover, Germany
关键词: complications;    postoperative hemorrhage;    urinoma;    nephron-sparing surgery;    renal cell carcinoma;   
Others  :  1206638
DOI  :  10.1186/1477-7819-9-126
 received in 2011-05-25, accepted in 2011-10-12,  发布年份 2011
PDF
【 摘 要 】

Background

Whenever technically feasible and oncologically justified, nephron-sparing surgery is the current standard of care for localized renal cell carcinomas (RCC). The main complications of partial nephrectomy, especially for large and centrally located tumors, are urinary leakage and parenchymal bleeding. We prospectively evaluated the pros and cons of using porcine small intestinal submucosa (SIS, Surgisis®) to close the renal defect after nephron-sparing surgery.

Methods

We used Surgisis® (Cook medical, Bloomington, IN, USA) to secure and compress the capsular defect after tumor resection in 123 patients submitted to 129 partial nephrectomies between August 2003 and February 2011.

Results

The median tumor size was 3.7 cm (range 1.1-13.0 cm). Procedures were performed with cold ischemia in 24 cases (18.2%), with warm ischemia in 46 (35.6%), and without ischemia in 59 cases (44.8%). In the total group of patients, 4 (3.1%) developed urinary fistula, and only 2 (1.6%) required postoperative transfusions due to hemorrhage after the application of the small intestinal submucosa membrane.

Conclusion

Small intestinal submucosa is an easy-to-use biomaterial for preventing complications such as postoperative bleeding and urinary fistula in nephron-sparing surgery, especially in cases where tumor excision causes significant renal capsular and/or renal pelvic defects.

【 授权许可】

   
2011 Schnoeller et al; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20150528083349237.pdf 3007KB PDF download
Figure 4. 110KB Image download
Figure 3. 42KB Image download
Figure 2. 90KB Image download
Figure 1. 28KB Image download
【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】
  • [1]Ljungberg B, Cowan NC, Hanbury DC, Hora M, Kuczyk MA, Merseburger AS, Patard JJ, Mulders PF, Sinescu IC: EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 2010, 58:398-406.
  • [2]Van Poppel H, Da Pozzo L, Albrecht W, Matveev V, Bono A, Borkowski A, Marechal JM, Klotz L, Skinner E, Keane T, et al.: A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2007, 51:1606-1615.
  • [3]Lughezzani G, Jeldres C, Budaus L, Shariat SF, Liberman D, Thuret R, Widmer H, Arjane P, Patard JJ, Perrotte P, et al.: The effect of radical versus partial nephrectomy on other-cause mortality in patients with T1a renal cell carcinoma: results from the surveillance, epidemiology and end results database. J Urol 2010., 183AUA abstract 826
  • [4]Derweesh I, Jolla L, Mehrazin R, Bazzi W, Kopp R, Silberstein J, Belderian S, Shiau J, Chenoweth M, Downs T, et al.: Variations in incidence of and risk factors for development of diabetes mellitus after radical or partial nephrectomy. J Urol 2010., 183AUA abstract 814
  • [5]Thompson RH, Boorjian SA, Lohse CM, Leibovich BC, Kwon ED, Cheville JC, Blute ML: Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol 2008, 179:468-471. discussion 472-463
  • [6]Miller DC, Ruterbusch J, Colt JS, Davis FG, Linehan WM, Chow WH, Schwartz K: Contemporary clinical epidemiology of renal cell carcinoma: insight from a population based case-control study. J Urol 184:2254-2258.
  • [7]Uzzo RG, Novick AC: Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol 2001, 166:6-18.
  • [8]Lerner SE, Hawkins CA, Blute ML, Grabner A, Wollan PC, Eickholt JT, Zincke H: Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. J Urol 1996, 155:1868-1873.
  • [9]Margulis V, Tamboli P, Jacobsohn KM, Swanson DA, Wood CG: Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma. BJU Int 2007, 100:1235-1239.
  • [10]Gill IS, Kavoussi LR, Lane BR, Blute ML, Babineau D, Colombo JR Jr, Frank I, Permpongkosol S, Weight CJ, Kaouk JH, et al.: Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol 2007, 178:41-46.
  • [11]Duque JL, Loughlin KR, O'Leary MP, Kumar S, Richie JP: Partial nephrectomy: alternative treatment for selected patients with renal cell carcinoma. Urology 1998, 52:584-590.
  • [12]Schiff JD, Palese M, Vaughan ED Jr, Sosa RE, Coll D, Del Pizzo JJ: Laparoscopic vs open partial nephrectomy in consecutive patients: the Cornell experience. BJU Int 2005, 96:811-814.
  • [13]Becker F, Siemer S, Hack M, Humke U, Ziegler M, Stockle M: Excellent long-term cancer control with elective nephron-sparing surgery for selected renal cell carcinomas measuring more than 4 cm. Eur Urol 2006, 49:1058-1063. discussion 1063-1054
  • [14]Belldegrun A, Tsui KH, deKernion JB, Smith RB: Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system. J Clin Oncol 1999, 17:2868-2875.
  • [15]Van Poppel H, Bamelis B, Oyen R, Baert L: Partial nephrectomy for renal cell carcinoma can achieve long-term tumor control. J Urol 1998, 160:674-678.
  • [16]Clough A, Ball J, Smith GS, Leibman S: Porcine small intestine submucosa matrix (Surgisis) for esophageal perforation. Ann Thorac Surg 2011, 91:e15-16.
  • [17]Lupinacci RM, Vallet C, Parc Y, Chafai N, Tiret E: Treatment of fistula-in-ano with the Surgisis((R)) AFP(TM) anal fistula plug. Gastroenterol Clin Biol 2011, 34:549-553.
  • [18]Khong SY, Lam A: Use of Surgisis mesh in the management of polypropylene mesh erosion into the vagina. Int Urogynecol J Pelvic Floor Dysfunct 2011, 22:41-46.
  • [19]Ecke TH, Hallmann S, Gerullis H, Ruttloff J: Reconstruction of the urethra with a Surgisis onlay patch in urethral reconstructive surgery: two case reports. J Med Case Reports 2009, 3:7232. BioMed Central Full Text
  • [20]Simon J, de Petriconi R, Meilinger M, Hautmann RE, Bartsch G Jr: Optimized haemostasis in nephron-sparing surgery using small-intestine submucosa. BMC Urol 2008, 8:8. BioMed Central Full Text
  • [21]O'Connor RC, Harding JN, Steinberg GD: Novel modification of partial nephrectomy technique using porcine small intestine submucosa. Urology 2002, 60:906-909.
  • [22]Gupta G, Peterson J, Daryanani D, Pinto P, Linehan WM, Bratslavsky G: Oncologic outcomes of partial nephrectomy for multifocal renal cell carcinoma with largest tumor greater then 4 cm. J Urol 2010., 183AUA abstract 986
  • [23]Weight C, Lieser G, Larson B, Lygothe C, Lane B, Campbell S, Kaouk J, Gill I, Fergany A: Pathological upstaging does not affect survival in patients with pT2/T3 renal tumors treated by either partial nephrectomy or radical nephrectomy. J Urol 2010., 183AUA abstract 1241
  • [24]Simhan J, Uzzo R, Chen D, Boorjian S, Scoll B, Viterbo R: Open, laparoscopic, and robotic partial nephrectomy: a single institution analysis with perioperative and oncologic outcomes. J Urol 2010., 183AUA abstract 988
  • [25]Lane B, Weight C, Campbell S: Renal functional outcomes after partial nephrectomy with extended ischemic intervals are better than after radical nephrectomy. J Urol 2010., 183AUA abstract 815
  • [26]Simon J, Finter F, Ignatius A, Meilinger M, Durselen L: Maximum tensile force of different suture techniques in reconstruction of the renal remnant after nephron-sparing surgery. Surg Endosc 2011, 25:503-507.
  • [27]Oz MC, Cosgrove DM, Badduke BR, Hill JD, Flannery MR, Palumbo R, Topic N: Controlled clinical trial of a novel hemostatic agent in cardiac surgery. The Fusion Matrix Study Group. Ann Thorac Surg 2000, 69:1376-1382.
  • [28]Badylak SF: Small intestine submucosa (SIS): a biomateral conducive to smart tissue remodeling. In Tissue Engineering: Current Perspectives. Edited by E B. Cambridge, Massachusetts: Burkhauser Publishers; 1993:179-189.
  文献评价指标  
  下载次数:34次 浏览次数:20次